Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

British Oxfam Urges Thailand Not To Scrap Compulsory-Licensing Policy

This article was originally published in PharmAsia News

Executive Summary

Oxfam, an England-based non-government organization, called on the new government in Thailand to maintain the compulsory-licensing policy of the previous government as a way to keep the prices of life-saving drugs affordable. The group's HIV/AIDS director expressed his concern based on the new government's decision to review the policy. The director said the actions of the previous military-led administration made key AIDS drugs, Bristol-Myers Squibb's Stocrin (efavirenx), sold in the United States as Sustiva, and Abbott Laboratories' version Kaletra (lopinavir, ritonavir), more accessible to more than 120,000 patients. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel